Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4439-4446

  Yang, Jun Qi ^a   Saxena, Vijay ^a   Xu, Honglin ^b   Van Kaer, Luc ^c   Wang, Chyung Ru ^b   Singh, Ram Raj ^a,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIGEN; CD1D ANTIGEN; CERAMIDE DERIVATIVE; CYTOKINE; GLYCOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATITIS; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; LUPUS ERYTHEMATOSUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0141889082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4439     Document Type: Article

References (36)

1. Malaviya, A. N., R. R. Singh, A. Kumar, A. De, A. Kumar, and S. Aradhye. 1988. Systemic lupus erythematosus in India: a review of 329 cases. J. Assoc. Physicians India 36:476.
2. Theofilopoulos, A. N., R. Kofler, P. A. Singer, and F. J. Dixon. 1989. Molecular genetics of murine lupus models. Adv. Immunol. 46:61.
3. Kanauchi, H., F. Furukawa, and S. Imamura. 1991. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J. Invest. Dermatol. 96:478.
4. Furukawa, F., H. Tanaka, K. Sekita, T. Nakamura, Y. Horiguchi, and Y. Hamashima. 1984. Dermatopathological studies on skin lesions of MRL mice. Arch. Dermatol. Res. 276:186.
5. + T lymphocytes. Science 268:863.
6. Hammond, K. J., and D. I. Godfrey. 2002. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59:353.
7. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
8. Wang, B., Y. B. Geng, and C. R. Wang. 2001. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes J. Exp. Med. 194:313.
9. Naumov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzer, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98:13838.
10. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531.
11. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
12. Takeda, K., and G. Dennert. 1993. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 177:155.
13. - NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
14. Sumida, T., A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi. 1995. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163.
15. Oishi, Y., T. Sumida, A. Sakamoto, Y. Kita, K. Kurasawa, Y. Nawata, K. Takabayasbi, H. Takahashi, S. Yoshida, M. Taniguchi, et al. 2001. Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 28:275.
16. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:144.
17. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44:1127.
18. Yang, J. Q., A. K. Singh, M. T. Wilson, M. Satoh, A. K. Stanic, J. Park, S. Hong, S. D. Gadola, A. Mizutani, S. R. Kakumanu, et al. 2003. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J. Immunol. 171:2142.
19. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741.
20. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38:2176.
21. Singh, R. R., B. H. Hahn, and E. E. Sercarz. 1996. Neonatal peptide exposure can prime T cells, and upon subsequent immunization induce their immune deviation: implications for antibody-vs T cell-mediated autoimmunity. J. Exp. Med. 183:1613.
22. H-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 196:731.
23. Gutierrez-Ramos, J. C., J. L. Andreu, Y. Revilla, E. Vinuela, and C. Martinez. 1990. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 346:271.
24. Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-γ-producing NKT response induced with α -galactosylceramide-loaded DCs. Nat. Immunol. 3:867.
25. Eberl, G., and H. R. MacDonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345.
26. Wilson, M. T., C. Johansson, D. Olivares-Villagonmez, A. K. Singh, A. K. Stanic, C. R. Wang, S. Joyce, M. J. Wick, and L. Van Kaer. 2003. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA. In press.
27. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require ltk for efficient maturation. J. Immunol. 169:2397.
28. Singh, R. R., V. Saxena, S. Zang, L. Li, F. D. Finkelman, D. P. Witte, and C. O. Jacob. 2003. Differential contribution of IL-4 and STAT6 versus STAT4 to the development of lupus nephritis. J. Immunol. 170:4818.
29. lpr mice: an example of disease regulation at the organ level. J. Immunol. 167:2985.
30. Peng, S. L., J. M. McNiff, M. P. Madaio, J. Ma, M. J. Owen, R. A. Flavell, A. C. Hayday, and J. Craft. 1997. αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158:2464.
31. lpr mice. J. Clin. Invest. 101:696.
32. Kanauchi, H., F. Furukawa, and S. Imamura. 1989. Evaluation of ATPase-positive Langerhans' cells in skin lesions of lupus erythematosus and experimentally induced inflammations. Arch. Dermatol. Res. 281:327.
33. Sanchez, R., R. Jonsson, and A. Tarkowski. 1988. Phenotypes of immunocompetent cells and Ia antigen expression in oral mucosa and skin of autoimmune mouse strains. Autoimmunity 1:243.
34. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296:553.
35. + CD1d-dependent precursor stage. J. Exp. Med. 195:835.
36. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112.